Cargando…

Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians

PURPOSE: Adherence to treatment can be defined as the degree to which a patient’s behavior is consonant with medical or health advice he or she receive as part of his treatment regimen. The aim of this study was: 1) to measure the rate of treatment adherence to among patients with lung cancer from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Souliotis, Kyriakos, Peppou, Lily E, Economou, Marina, Marioli, Androniki, Nikolaidi, Sofia, Saridi, Maria, Varvaras, Dimitrios, Paschali, Antonia, Syrigos, Konstantinos N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418830/
https://www.ncbi.nlm.nih.gov/pubmed/34181348
http://dx.doi.org/10.31557/APJCP.2021.22.6.1891
_version_ 1783748640764854272
author Souliotis, Kyriakos
Peppou, Lily E
Economou, Marina
Marioli, Androniki
Nikolaidi, Sofia
Saridi, Maria
Varvaras, Dimitrios
Paschali, Antonia
Syrigos, Konstantinos N
author_facet Souliotis, Kyriakos
Peppou, Lily E
Economou, Marina
Marioli, Androniki
Nikolaidi, Sofia
Saridi, Maria
Varvaras, Dimitrios
Paschali, Antonia
Syrigos, Konstantinos N
author_sort Souliotis, Kyriakos
collection PubMed
description PURPOSE: Adherence to treatment can be defined as the degree to which a patient’s behavior is consonant with medical or health advice he or she receive as part of his treatment regimen. The aim of this study was: 1) to measure the rate of treatment adherence to among patients with lung cancer from the prospect of both patients and physicians, 2) to measure the degree of concordance between the two prospect, and 3) to identify factors related to adherence for both prospect (patients and physicians). MATERIALS AND METHODS: A total of 250 patients were included in this study. Information about socio-economic characteristics, depressive and anxiety symptoms (Hospital Anxiety and Depression scale), nicotine dependence (Fagerstrom scale), barriers to accessing care, and the level of treatment adherence was collected through interview. Physicians were enquired about disease and treatment variables as well as patients’ level of adherence. RESULTS: From the patient perspective, only 1.2% of patients displayed poor adherence; whereas the corresponding percentage among physicians was 12.4%. The concordance between the two was low: 0.244. The correlation of measurements made on the same individual was found to be equal to 0.14. Barriers to accessing medication (O.R.=2.82, 95% C.I.: 1.01-8.09) was the only risk factor when adherence was self-rated; barriers to accessing medication (O.R.=2.45, 95% C.I.: 1.03-5.86), education equal to 12 years (O.R.=0.33, 95% C.I.: 0.13-0.82) or higher than 12 years (O.R.=0.28, 95% C.I.: 0.08-0.96), nicotine dependence (O.R.=1.41, 95% C.I. 1.17-1.69) and HADS anxiety score (O.R.=1.15, 95% C.I. 1.03-1.30) were the predictors in physicians’ rating. CONCLUSIONS: Differences in rating adherence may underpin communication gaps between patients and physicians. Systemic determinants of poor adherence should not be overlooked. A concerted effort by researchers, physicians and policy makers in defining as well as communicating adherence, while removing its barriers should be made.
format Online
Article
Text
id pubmed-8418830
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-84188302021-09-10 Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians Souliotis, Kyriakos Peppou, Lily E Economou, Marina Marioli, Androniki Nikolaidi, Sofia Saridi, Maria Varvaras, Dimitrios Paschali, Antonia Syrigos, Konstantinos N Asian Pac J Cancer Prev Research Article PURPOSE: Adherence to treatment can be defined as the degree to which a patient’s behavior is consonant with medical or health advice he or she receive as part of his treatment regimen. The aim of this study was: 1) to measure the rate of treatment adherence to among patients with lung cancer from the prospect of both patients and physicians, 2) to measure the degree of concordance between the two prospect, and 3) to identify factors related to adherence for both prospect (patients and physicians). MATERIALS AND METHODS: A total of 250 patients were included in this study. Information about socio-economic characteristics, depressive and anxiety symptoms (Hospital Anxiety and Depression scale), nicotine dependence (Fagerstrom scale), barriers to accessing care, and the level of treatment adherence was collected through interview. Physicians were enquired about disease and treatment variables as well as patients’ level of adherence. RESULTS: From the patient perspective, only 1.2% of patients displayed poor adherence; whereas the corresponding percentage among physicians was 12.4%. The concordance between the two was low: 0.244. The correlation of measurements made on the same individual was found to be equal to 0.14. Barriers to accessing medication (O.R.=2.82, 95% C.I.: 1.01-8.09) was the only risk factor when adherence was self-rated; barriers to accessing medication (O.R.=2.45, 95% C.I.: 1.03-5.86), education equal to 12 years (O.R.=0.33, 95% C.I.: 0.13-0.82) or higher than 12 years (O.R.=0.28, 95% C.I.: 0.08-0.96), nicotine dependence (O.R.=1.41, 95% C.I. 1.17-1.69) and HADS anxiety score (O.R.=1.15, 95% C.I. 1.03-1.30) were the predictors in physicians’ rating. CONCLUSIONS: Differences in rating adherence may underpin communication gaps between patients and physicians. Systemic determinants of poor adherence should not be overlooked. A concerted effort by researchers, physicians and policy makers in defining as well as communicating adherence, while removing its barriers should be made. West Asia Organization for Cancer Prevention 2021-06 /pmc/articles/PMC8418830/ /pubmed/34181348 http://dx.doi.org/10.31557/APJCP.2021.22.6.1891 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Souliotis, Kyriakos
Peppou, Lily E
Economou, Marina
Marioli, Androniki
Nikolaidi, Sofia
Saridi, Maria
Varvaras, Dimitrios
Paschali, Antonia
Syrigos, Konstantinos N
Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians
title Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians
title_full Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians
title_fullStr Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians
title_full_unstemmed Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians
title_short Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians
title_sort treatment adherence in patients with lung cancer from prospects of patients and physicians
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418830/
https://www.ncbi.nlm.nih.gov/pubmed/34181348
http://dx.doi.org/10.31557/APJCP.2021.22.6.1891
work_keys_str_mv AT souliotiskyriakos treatmentadherenceinpatientswithlungcancerfromprospectsofpatientsandphysicians
AT peppoulilye treatmentadherenceinpatientswithlungcancerfromprospectsofpatientsandphysicians
AT economoumarina treatmentadherenceinpatientswithlungcancerfromprospectsofpatientsandphysicians
AT marioliandroniki treatmentadherenceinpatientswithlungcancerfromprospectsofpatientsandphysicians
AT nikolaidisofia treatmentadherenceinpatientswithlungcancerfromprospectsofpatientsandphysicians
AT saridimaria treatmentadherenceinpatientswithlungcancerfromprospectsofpatientsandphysicians
AT varvarasdimitrios treatmentadherenceinpatientswithlungcancerfromprospectsofpatientsandphysicians
AT paschaliantonia treatmentadherenceinpatientswithlungcancerfromprospectsofpatientsandphysicians
AT syrigoskonstantinosn treatmentadherenceinpatientswithlungcancerfromprospectsofpatientsandphysicians